Sorrento Therapeutics, Inc. 4
4 · Sorrento Therapeutics, Inc. · Filed Oct 31, 2013
Insider Transaction Report
Form 4
AFTING ERNST-GUNTER
Director
Transactions
- Award
Stock Options
2013-10-29+9,000→ 26,600 totalExercise: $8.40Exp: 2023-10-29→ Common Stock (9,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one-month period of service starting on September 6, 2013, subject to the reporting person's continued service on the issuer's board of directors on each such date.